Synapse - Works

Results (4760)

Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors

Meeting Abstract

Hyman, D. M.; Tran, B.; Jaime, J. C.; Garralda, E.; Machiels, J. P. H.; Schellens, J. H. M.; Bedard, P.; Campone, M.; Cassier, P.; Sarantopoulos, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Preliminary results from the first in human study of activin-A inhibitor, STM434, in patients with granulosa cell ovarian cancer and other advanced solid tumors

Meeting Abstract

Hyman, D. M.; Rasco, D. W.; Infante, J. R.; Liu, J. F.; Welkowsky, E.; Thai, D. L.; Haqq, C. M.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

TAGS, a randomized, double-blind, phase 3 study evaluating TAS-102 plus best supportive care vs placebo plus best supportive care in patients with metastatic gastric cancer refractory to standard treatments

Meeting Abstract

Ilson, D. H.; Tabernero, J.; Shitara, K.; Winkler, R.; Nasermoaddeli, A.; Ding, C.; Doi, T.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors

Meeting Abstract

Infante, J. R.; Ahlers, C. M.; Hodi, F. S.; Postel-Vinay, S.; Schellens, J. H. M.; Heymach, J.; Autio, K. A.; Barnette, M. S.; Struemper, H.; Watmuff, M.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab (pembro)

Meeting Abstract

Hui, R.; Gandhi, L.; Costa, E. C.; Felip, E.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Leighl, N. B.; Aggarwal, C.; Horn, L.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Overall survival in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase II trial (CheckMate 069)

Meeting Abstract

Hodi, F. S.; Postow, M. A.; Chesney, J. A.; Pavlick, A. C.; Robert, C.; Grossmann, K. F.; McDermott, D. F.; Linette, G. P.; Meyer, N.; Giguere, J. K.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

HPV cell free DNA as a marker of response to chemoradiation for HPV-positive oropharngeal cancers

Meeting Abstract

Higginson, D. S.; Damerla, R.; Scher, E. D.; Gutinov, S. I.; Thompson, C.; Cleary, C.; McBride, S. M.; Sherman, E. J.; Riaz, N.; Lee, N.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

ADXS11-001 immunotherapy in squamous or non-squamous persistent/recurrent metastatic cervical cancer: Results from stage I of the phase II GOG/NRG0265 study

Meeting Abstract

Huh, W. K.; Dizon, D. S.; Powell, M. A.; Leath, C. A.; Landrum, L. M.; Tanner, E.; Higgins, R.; Ueda, S. M.; McHale, M. T.; Monk, B. J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma

Meeting Abstract

Ho, A. L.; Sherman, E. J.; Baxi, S. S.; Haque, S.; Ni, A.; Antonescu, C. R.; Katabi, N.; Morris, L. G.; Chan, T. A. T.; Pfister, D. G.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

18F 2Fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) response to predict event-free survival (EFS) in intermediate risk (IR) or high risk (HR) rhabdomyosarcoma (RMS): A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (COG)

Meeting Abstract

Harrison, D. J.; Parisi, M. T.; Shulkin, B. L.; Chi, Y. Y.; Anderson, J. R.; Mi, X.; Malempati, S.; Mascarenhas, L.; McCowage, G. B.; Weigel, B.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save